跳至主要内容
临床试验/JPRN-UMIN000027600
JPRN-UMIN000027600
招募中
未知

A pilot study to examine the safety of combination with selective COX2 inhibitor meloxicam before autologous peripheral blood stem cell harvest and the collection efficiency of hematopoietic stem cells - The safety of meloxicam before autologous PBSCH and the collection efficiency of hematopoietic stem cells

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Patients with multiple myeloma who receive autologous peripheral blood stem cell harvest
发起方
Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
入组人数
5
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2017年6月2日
结束日期
待定
最后更新
2年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 未提供

排除标准

  • 1\)Patients who are not eligible for apheresis 2\)Allergy to meloxicam 3\)Patients who cannot take medicine orally on the 10th day after the administration of the anticancer drug 4\)Patients with bleeding tendency before treatment 5\)Patients who are difficult to maintain platelets more than 20,000/mm3 even if appropriate measures such as platelet transfusion are done 6\)Patients with active gastrointestinal ulcer 7\)Patients with severe renal dysfunction (G3b or more in GFR classification) 8\)Patients with aspirin\-induced asthma or a history of aspirin\-induced asthma 9\)Inadequate condition as diagnosed by primary physician

结局指标

主要结局

未指定

相似试验